Zacks.com Quotes and Research

MEDIFAST INC (NYSE)
MED 27.63 0.06 (0.22%) Vol.  338,473 14:40 ET

Day Low - High 27.00 - 27.95
52wk Low - High 3.63 - 28.67
Avg Volume 818,038
Industry FOOD-MISC/DIVERSIFIED
Market Cap 420.47 M
Div - Yield 0.00 - 0.00
PE (forward) 34.46
PEG Ratio N/A
Current Year Est. .8
EPS Last Year 0.67
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
#1 Strong Buy 26.51%
#2 Buy 16.63%
#3 Hold 7.53%
#4 Sell 2.01%
#5 Strong Sell -0.07%
S&P 500 8.70%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


upgraded 11/04/2009
Short-Term Rating 1-3 Months
PREMIUM
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 11/18/2009
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
MEDIFAST INC MED PREMIUM
NBTY INC NTY PREMIUM
SUNOPTA INC-TS T.SOY PREMIUM
CADBURY PLC CBY PREMIUM
See all FOOD-MISC/DIVERSIFIED Peers

BROKERAGE RECOMMENDATIONS
Current ABR 1.00
ABR (Last Week) 1.00
# of Recs in ABR 1
Average Target Price 31.00
Industry Rank by ABR 28 out of 217
Rank in Industry 1 out of 43
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate MED?
Buy
Sell
Find out what the Zacks Community
thinks of MED at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart



 
ZACKS COMMENTARY FOR MED
Zacks Equity Research: Report for MED
Nov 18, 2009
Value: Medifast, Inc.
Jan 05, 2009
Zacks Blog: Zacks #1 Rank Additions for Friday
Nov 28, 2008
More Zacks Commentary
NEWS
Medifast Up 11.8% Since SmarTrend's Buy Recommendation
Nov 23, 2009
The Fortune Financial Research Partners Tracking Lions GateEntertainment Corp., Quiksilver Inc., Medifast Inc., Ocean FreightInc., Scientific Games Corp. and Google Inc.
Nov 20, 2009
Stock research report available on Medifast (NYSE:MED) from SmarTrend Analytics
Nov 16, 2009
Medifast Up 10.9% Since SmarTrend's Buy Recommendation
Nov 09, 2009
Medifast (MED) NewsBite - MED Falls on Economic Worries
Nov 06, 2009
More News
EARNINGS ESTIMATES
  This Quarter
12/2009
Next Quarter
03/2010
This Year
12/2009
Next Year
12/2010
Average Estimate 0.19 0.26 0.80 1.05
Number of Estimates 1 1 1 1
Low Estimates 0.19 0.26 0.80 1.05
High Estimate 0.19 0.26 0.80 1.05
Year Ago EPS 0.07 0.17 0.38 0.80
EPS Growth 171.43% 52.94% 110.53% 31.25%

More Estimates

COMPANY DESCRIPTION
Medifast Inc has one operating subsidiary, Jason Pharmaceuticals, Inc, its manufacturing arm. They are engaged in the production, distribution, and sale of consumable health and diet products. Their product lines include weight management, meal replacement and sports nutrition products manufactured in a modern facility in Owings Mills, Maryland.

Full Company Report
FINANCIALS
EPS TTM .67
Sales 105.44
Net Income 9.87
Price/Earnings 41.15
Price/Book 8.68
Price/Cash Flow 39.49
Price/Sales 2.9


More Financials